カテゴリー： QYResearch, 世界

世界のペプチド抗生物質市場 2019年

【英語タイトル】Global Peptide Antibiotics Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X12780）・商品コード：DATA909X12780
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：114
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ペプチド抗生物質の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、リボソーム合成ペプチド抗生物質、非リボソーム合成ペプチド抗生物質に、用途別には、製薬＆ヘルスケア、食品産業、商品、その他にセグメント区分し、ペプチド抗生物質の世界市場を分析しました。


・エグゼクティブ・サマリー
・ペプチド抗生物質の世界市場概要
・ペプチド抗生物質の製造コスト構成分析
・ペプチド抗生物質の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ペプチド抗生物質の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ペプチド抗生物質のセグメント分析（種類別）
（リボソーム合成ペプチド抗生物質、非リボソーム合成ペプチド抗生物質）
・ペプチド抗生物質のセグメント分析（用途別）
（製薬＆ヘルスケア、食品産業、商品、その他）
・ペプチド抗生物質の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Pfizer、Novartis、GlaxoSmithKline、Eli Lilly、Theravance、Vicuron Pharmaceuticals、Savara Pharmaceuticals、AMP Therapeutics、Hospira、Kasten、Madam Therapeutics、Phosphagenics、Pacgen Life Science Corporation、）
・ペプチド抗生物質の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Peptide Antibiotics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Peptide Antibiotics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Peptide Antibiotics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Peptide Antibiotics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Peptide Antibiotics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Novartis
GlaxoSmithKline
Eli Lilly
Theravance
Vicuron Pharmaceuticals
Savara Pharmaceuticals
AMP Therapeutics
Hospira
Kasten
Madam Therapeutics
Phosphagenics
Pacgen Life Science Corporation

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomally Synthesized Peptide Antibiotics

Segment by Application
Pharma & Healthcare
Food Industry
Commodities
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Peptide Antibiotics
1.1 Definition of Peptide Antibiotics
1.2 Peptide Antibiotics Segment by Type
1.2.1 Global Peptide Antibiotics Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Ribosomal Synthesized Peptide Antibiotics
1.2.3 Non-Ribosomally Synthesized Peptide Antibiotics
1.3 Peptide Antibiotics Segment by Applications
1.3.1 Global Peptide Antibiotics Consumption Comparison by Applications (2014-2025)
1.3.2 Pharma & Healthcare
1.3.3 Food Industry
1.3.4 Commodities
1.3.5 Other
1.4 Global Peptide Antibiotics Overall Market
1.4.1 Global Peptide Antibiotics Revenue (2014-2025)
1.4.2 Global Peptide Antibiotics Production (2014-2025)
1.4.3 North America Peptide Antibiotics Status and Prospect (2014-2025)
1.4.4 Europe Peptide Antibiotics Status and Prospect (2014-2025)
1.4.5 China Peptide Antibiotics Status and Prospect (2014-2025)
1.4.6 Japan Peptide Antibiotics Status and Prospect (2014-2025)
1.4.7 Southeast Asia Peptide Antibiotics Status and Prospect (2014-2025)
1.4.8 India Peptide Antibiotics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Peptide Antibiotics
2.3 Manufacturing Process Analysis of Peptide Antibiotics
2.4 Industry Chain Structure of Peptide Antibiotics

3 Development and Manufacturing Plants Analysis of Peptide Antibiotics
3.1 Capacity and Commercial Production Date
3.2 Global Peptide Antibiotics Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Peptide Antibiotics
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Peptide Antibiotics Production and Capacity Analysis
4.2 Peptide Antibiotics Revenue Analysis
4.3 Peptide Antibiotics Price Analysis
4.4 Market Concentration Degree

5 Peptide Antibiotics Regional Market Analysis
5.1 Peptide Antibiotics Production by Regions
5.1.1 Global Peptide Antibiotics Production by Regions
5.1.2 Global Peptide Antibiotics Revenue by Regions
5.2 Peptide Antibiotics Consumption by Regions
5.3 North America Peptide Antibiotics Market Analysis
5.3.1 North America Peptide Antibiotics Production
5.3.2 North America Peptide Antibiotics Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Peptide Antibiotics Import and Export
5.4 Europe Peptide Antibiotics Market Analysis
5.4.1 Europe Peptide Antibiotics Production
5.4.2 Europe Peptide Antibiotics Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Peptide Antibiotics Import and Export
5.5 China Peptide Antibiotics Market Analysis
5.5.1 China Peptide Antibiotics Production
5.5.2 China Peptide Antibiotics Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Peptide Antibiotics Import and Export
5.6 Japan Peptide Antibiotics Market Analysis
5.6.1 Japan Peptide Antibiotics Production
5.6.2 Japan Peptide Antibiotics Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Peptide Antibiotics Import and Export
5.7 Southeast Asia Peptide Antibiotics Market Analysis
5.7.1 Southeast Asia Peptide Antibiotics Production
5.7.2 Southeast Asia Peptide Antibiotics Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Peptide Antibiotics Import and Export
5.8 India Peptide Antibiotics Market Analysis
5.8.1 India Peptide Antibiotics Production
5.8.2 India Peptide Antibiotics Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Peptide Antibiotics Import and Export

6 Peptide Antibiotics Segment Market Analysis (by Type)
6.1 Global Peptide Antibiotics Production by Type
6.2 Global Peptide Antibiotics Revenue by Type
6.3 Peptide Antibiotics Price by Type

7 Peptide Antibiotics Segment Market Analysis (by Application)
7.1 Global Peptide Antibiotics Consumption by Application
7.2 Global Peptide Antibiotics Consumption Market Share by Application (2014-2019)

8 Peptide Antibiotics Major Manufacturers Analysis
8.1 Pfizer
8.1.1 Pfizer Peptide Antibiotics Production Sites and Area Served
8.1.2 Pfizer Product Introduction, Application and Specification
8.1.3 Pfizer Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Novartis
8.2.1 Novartis Peptide Antibiotics Production Sites and Area Served
8.2.2 Novartis Product Introduction, Application and Specification
8.2.3 Novartis Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 GlaxoSmithKline
8.3.1 GlaxoSmithKline Peptide Antibiotics Production Sites and Area Served
8.3.2 GlaxoSmithKline Product Introduction, Application and Specification
8.3.3 GlaxoSmithKline Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Eli Lilly
8.4.1 Eli Lilly Peptide Antibiotics Production Sites and Area Served
8.4.2 Eli Lilly Product Introduction, Application and Specification
8.4.3 Eli Lilly Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Theravance
8.5.1 Theravance Peptide Antibiotics Production Sites and Area Served
8.5.2 Theravance Product Introduction, Application and Specification
8.5.3 Theravance Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Vicuron Pharmaceuticals
8.6.1 Vicuron Pharmaceuticals Peptide Antibiotics Production Sites and Area Served
8.6.2 Vicuron Pharmaceuticals Product Introduction, Application and Specification
8.6.3 Vicuron Pharmaceuticals Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Savara Pharmaceuticals
8.7.1 Savara Pharmaceuticals Peptide Antibiotics Production Sites and Area Served
8.7.2 Savara Pharmaceuticals Product Introduction, Application and Specification
8.7.3 Savara Pharmaceuticals Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 AMP Therapeutics
8.8.1 AMP Therapeutics Peptide Antibiotics Production Sites and Area Served
8.8.2 AMP Therapeutics Product Introduction, Application and Specification
8.8.3 AMP Therapeutics Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Hospira
8.9.1 Hospira Peptide Antibiotics Production Sites and Area Served
8.9.2 Hospira Product Introduction, Application and Specification
8.9.3 Hospira Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Kasten
8.10.1 Kasten Peptide Antibiotics Production Sites and Area Served
8.10.2 Kasten Product Introduction, Application and Specification
8.10.3 Kasten Peptide Antibiotics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Madam Therapeutics
8.12 Phosphagenics
8.13 Pacgen Life Science Corporation

9 Development Trend of Analysis of Peptide Antibiotics Market
9.1 Global Peptide Antibiotics Market Trend Analysis
9.1.1 Global Peptide Antibiotics Market Size (Volume and Value) Forecast 2019-2025
9.2 Peptide Antibiotics Regional Market Trend
9.2.1 North America Peptide Antibiotics Forecast 2019-2025
9.2.2 Europe Peptide Antibiotics Forecast 2019-2025
9.2.3 China Peptide Antibiotics Forecast 2019-2025
9.2.4 Japan Peptide Antibiotics Forecast 2019-2025
9.2.5 Southeast Asia Peptide Antibiotics Forecast 2019-2025
9.2.6 India Peptide Antibiotics Forecast 2019-2025
9.3 Peptide Antibiotics Market Trend (Product Type)
9.4 Peptide Antibiotics Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Peptide Antibiotics Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Peptide Antibiotics
Table Global Peptide Antibiotics Production (MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Peptide Antibiotics Production Market Share by Types in 2018
Figure Ribosomal Synthesized Peptide Antibiotics Product Picture
Figure Non-Ribosomally Synthesized Peptide Antibiotics Product Picture
Table Global Peptide Antibiotics Consumption (MT) Comparison by Applications (2014-2025)
Figure Global Peptide Antibiotics Consumption Market Share by Applications in 2018
Figure Pharma & Healthcare
Figure Food Industry
Figure Commodities
Figure Other
Figure Global Peptide Antibiotics Revenue (Million USD) (2014-2025)
Figure Global Peptide Antibiotics Production (MT) (2014-2025)
Figure North America Peptide Antibiotics Market Size (Million USD) (2014-2025)
Figure Europe Peptide Antibiotics Market Size (Million USD) (2014-2025)
Figure China Peptide Antibiotics Market Size (Million USD) (2014-2025)
Figure Japan Peptide Antibiotics Market Size (Million USD) (2014-2025)
Figure Southeast Asia Peptide Antibiotics Market Size (Million USD) (2014-2025)
Figure India Peptide Antibiotics Market Size (Million USD) (2014-2025)
Table Peptide Antibiotics Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Peptide Antibiotics in 2018
Figure Manufacturing Process Analysis of Peptide Antibiotics
Figure Industry Chain Structure of Peptide Antibiotics
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Peptide Antibiotics Manufacturing Plants Distribution
Table Peptide Antibiotics Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Peptide Antibiotics Capacity (MT) of Major Manufacturers (2014-2019)
Table Peptide Antibiotics Production (MT) of Major Manufacturers (2014-2019)
Table Peptide Antibiotics Production Market Share of Major Manufacturers (2014-2019)
Figure Peptide Antibiotics Production Share by Manufacturers in 2018
Table Peptide Antibiotics Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Peptide Antibiotics Revenue Market Share of Major Manufacturers (2014-2019)
Figure Peptide Antibiotics Revenue Share by Manufacturers in 2018
Table Peptide Antibiotics Average Price (USD/Kg) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Peptide Antibiotics Production by Regions 2014-2019 (MT)
Table Global Peptide Antibiotics Production Market Share by Regions 2014-2019
Figure Global Peptide Antibiotics Production Market Share by Regions in 2018
Table Global Peptide Antibiotics Revenue by Regions 2014-2019 (Million USD)
Table Global Peptide Antibiotics Revenue Market Share by Regions 2014-2019
Figure Global Peptide Antibiotics Revenue Market Share by Regions in 2018
Table Global Peptide Antibiotics Consumption by Regions 2014-2019 (MT)
Table Global Peptide Antibiotics Consumption Market Share by Regions 2014-2019
Figure North America Peptide Antibiotics Production Growth Rate 2014-2019 (MT)
Figure North America Peptide Antibiotics Revenue Growth Rate 2014-2019 (Million USD)
Table North America Peptide Antibiotics Production, Consumption Import and Export (MT)
Figure Europe Peptide Antibiotics Production Growth Rate 2014-2019 (MT)
Figure Europe Peptide Antibiotics Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Peptide Antibiotics Production, Consumption Import and Export (MT)
Figure China Peptide Antibiotics Production Growth Rate 2014-2019 (MT)
Figure China Peptide Antibiotics Revenue Growth Rate 2014-2019 (Million USD)
Table China Peptide Antibiotics Production, Consumption Import and Export (MT)
Figure Japan Peptide Antibiotics Production Growth Rate 2014-2019 (MT)
Figure Japan Peptide Antibiotics Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Peptide Antibiotics Production, Consumption Import and Export (MT)
Figure Southeast Asia Peptide Antibiotics Production Growth Rate 2014-2019 (MT)
Figure Southeast Asia Peptide Antibiotics Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Peptide Antibiotics Production, Consumption Import and Export (MT)
Figure India Peptide Antibiotics Production Growth Rate 2014-2019 (MT)
Figure India Peptide Antibiotics Revenue Growth Rate 2014-2019 (Million USD)
Table India Peptide Antibiotics Production, Consumption Import and Export (MT)
Figure Global Consumption Peptide Antibiotics Market Share by Application (2014-2019)
Figure Global Value (Consumption) Peptide Antibiotics Market Share by Application (2014-2019)
Table Pfizer Peptide Antibiotics Production Sites and Area Served
Table Pfizer Peptide Antibiotics Product Introduction, Application and Specification
Table Pfizer Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Pfizer Peptide Antibiotics Production Growth Rate (2014-2019)
Table Pfizer Peptide Antibiotics Production Market Share (2014-2019)
Figure Pfizer Peptide Antibiotics Revenue Market Share (2014-2019)
Table Pfizer Peptide Antibiotics Main Business and Markets Served
Table Novartis Peptide Antibiotics Production Sites and Area Served
Table Novartis Peptide Antibiotics Product Introduction, Application and Specification
Table Novartis Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Novartis Peptide Antibiotics Production Growth Rate (2014-2019)
Table Novartis Peptide Antibiotics Production Market Share (2014-2019)
Figure Novartis Peptide Antibiotics Revenue Market Share (2014-2019)
Table Novartis Peptide Antibiotics Main Business and Markets Served
Table GlaxoSmithKline Peptide Antibiotics Production Sites and Area Served
Table GlaxoSmithKline Peptide Antibiotics Product Introduction, Application and Specification
Table GlaxoSmithKline Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table GlaxoSmithKline Peptide Antibiotics Production Growth Rate (2014-2019)
Table GlaxoSmithKline Peptide Antibiotics Production Market Share (2014-2019)
Figure GlaxoSmithKline Peptide Antibiotics Revenue Market Share (2014-2019)
Table GlaxoSmithKline Peptide Antibiotics Main Business and Markets Served
Table Eli Lilly Peptide Antibiotics Production Sites and Area Served
Table Eli Lilly Peptide Antibiotics Product Introduction, Application and Specification
Table Eli Lilly Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Eli Lilly Peptide Antibiotics Production Growth Rate (2014-2019)
Table Eli Lilly Peptide Antibiotics Production Market Share (2014-2019)
Figure Eli Lilly Peptide Antibiotics Revenue Market Share (2014-2019)
Table Eli Lilly Peptide Antibiotics Main Business and Markets Served
Table Theravance Peptide Antibiotics Production Sites and Area Served
Table Theravance Peptide Antibiotics Product Introduction, Application and Specification
Table Theravance Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Theravance Peptide Antibiotics Production Growth Rate (2014-2019)
Table Theravance Peptide Antibiotics Production Market Share (2014-2019)
Figure Theravance Peptide Antibiotics Revenue Market Share (2014-2019)
Table Theravance Peptide Antibiotics Main Business and Markets Served
Table Vicuron Pharmaceuticals Peptide Antibiotics Production Sites and Area Served
Table Vicuron Pharmaceuticals Peptide Antibiotics Product Introduction, Application and Specification
Table Vicuron Pharmaceuticals Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Vicuron Pharmaceuticals Peptide Antibiotics Production Growth Rate (2014-2019)
Table Vicuron Pharmaceuticals Peptide Antibiotics Production Market Share (2014-2019)
Figure Vicuron Pharmaceuticals Peptide Antibiotics Revenue Market Share (2014-2019)
Table Vicuron Pharmaceuticals Peptide Antibiotics Main Business and Markets Served
Table Savara Pharmaceuticals Peptide Antibiotics Production Sites and Area Served
Table Savara Pharmaceuticals Peptide Antibiotics Product Introduction, Application and Specification
Table Savara Pharmaceuticals Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Savara Pharmaceuticals Peptide Antibiotics Production Growth Rate (2014-2019)
Table Savara Pharmaceuticals Peptide Antibiotics Production Market Share (2014-2019)
Figure Savara Pharmaceuticals Peptide Antibiotics Revenue Market Share (2014-2019)
Table Savara Pharmaceuticals Peptide Antibiotics Main Business and Markets Served
Table AMP Therapeutics Peptide Antibiotics Production Sites and Area Served
Table AMP Therapeutics Peptide Antibiotics Product Introduction, Application and Specification
Table AMP Therapeutics Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table AMP Therapeutics Peptide Antibiotics Production Growth Rate (2014-2019)
Table AMP Therapeutics Peptide Antibiotics Production Market Share (2014-2019)
Figure AMP Therapeutics Peptide Antibiotics Revenue Market Share (2014-2019)
Table AMP Therapeutics Peptide Antibiotics Main Business and Markets Served
Table Hospira Peptide Antibiotics Production Sites and Area Served
Table Hospira Peptide Antibiotics Product Introduction, Application and Specification
Table Hospira Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Hospira Peptide Antibiotics Production Growth Rate (2014-2019)
Table Hospira Peptide Antibiotics Production Market Share (2014-2019)
Figure Hospira Peptide Antibiotics Revenue Market Share (2014-2019)
Table Hospira Peptide Antibiotics Main Business and Markets Served
Table Kasten Peptide Antibiotics Production Sites and Area Served
Table Kasten Peptide Antibiotics Product Introduction, Application and Specification
Table Kasten Peptide Antibiotics Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019)
Table Kasten Peptide Antibiotics Production Growth Rate (2014-2019)
Table Kasten Peptide Antibiotics Production Market Share (2014-2019)
Figure Kasten Peptide Antibiotics Revenue Market Share (2014-2019)
Table Kasten Peptide Antibiotics Main Business and Markets Served
Table Madam Therapeutics Peptide Antibiotics Production Sites and Area Served
Table Phosphagenics Peptide Antibiotics Production Sites and Area Served
Table Pacgen Life Science Corporation Peptide Antibiotics Production Sites and Area Served
Figure Global Peptide Antibiotics Production (MT) Growth Rate Forecast 2019-2025
Figure Global Peptide Antibiotics Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Peptide Antibiotics Sales Price (USD/Kg) Forecast 2019-2025
Figure North America Peptide Antibiotics Production Growth Rate Forecast 2019-2025 (MT)
Figure North America Peptide Antibiotics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Peptide Antibiotics Production Growth Rate Forecast 2019-2025 (MT)
Figure Europe Peptide Antibiotics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Peptide Antibiotics Production Growth Rate Forecast 2019-2025 (MT)
Figure China Peptide Antibiotics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Peptide Antibiotics Production Growth Rate Forecast 2019-2025 (MT)
Figure Japan Peptide Antibiotics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Peptide Antibiotics Production Growth Rate Forecast 2019-2025 (MT)
Figure Southeast Asia Peptide Antibiotics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Peptide Antibiotics Production Growth Rate Forecast 2019-2025 (MT)
Figure India Peptide Antibiotics Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (MT) of Peptide Antibiotics by Type (2019-2025)
Table Global Consumption (MT) of Peptide Antibiotics by Application (2019-2025)
Table Peptide Antibiotics Distributors List
Table Peptide Antibiotics Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Pfizer、Novartis、GlaxoSmithKline、Eli Lilly、Theravance、Vicuron Pharmaceuticals、Savara Pharmaceuticals、AMP Therapeutics、Hospira、Kasten、Madam Therapeutics、Phosphagenics、Pacgen Life Science Corporation、

★調査レポート[世界のペプチド抗生物質市場 2019年] (コード：DATA909X12780)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のペプチド抗生物質市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のグルカゴン様ペプチド2受容体市場 2019年
    DATA909X08497 / QYResearch / 2019年11月15日 / ※本調査レポートは、グルカゴン様ペプチド2受容体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、FE-203799、グレパグルチド、GXG-8、HM-15910、その他に、用途別には、短腸症候群、糖尿病、下痢、肥満、その他にセグメント区分し、グルカゴン様ペプチド2受容体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・グルカゴン様ペプチド2受容体の世界市場概要 ・グルカゴン様ペプチド2受容体の製造コスト構成分析 ・グルカゴン様ペプチド2受容体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・グルカゴン様ペプチド2受容体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・グルカゴン様ペプチド2受容体のセグメント分析（種類別） （FE-203799、グレパグルチド、GXG-8、HM-15910、その他）...The global Glucagon Like Peptide 2 Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Glucagon Like Peptide 2 Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Glucagon Like Peptide 2 Receptor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Glucagon Like Peptide 2 Receptor in North America, Europe, China, Japan, Southeast Asia and...
  • 世界のカルシトニン遺伝子関連ペプチド1型受容体市場 2019年
    DATA909X04955 / QYResearch / 2019年11月15日 / ※本調査レポートは、カルシトニン遺伝子関連ペプチド1型受容体の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AFAP-3、AGN-241689、CGRP、エレヌマブ、その他に、用途別には、心血管、代謝障害、歯痛、その他にセグメント区分し、カルシトニン遺伝子関連ペプチド1型受容体の世界市場を分析しました。 ・エグゼクティブ・サマリー ・カルシトニン遺伝子関連ペプチド1型受容体の世界市場概要 ・カルシトニン遺伝子関連ペプチド1型受容体の製造コスト構成分析 ・カルシトニン遺伝子関連ペプチド1型受容体の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・カルシトニン遺伝子関連ペプチド1型受容体の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・カルシトニン遺伝子関連ペプチド1型受容体のセグメント分析（種類別） （AFAP-3、AGN-241689、CGRP、エレヌマブ、その他）...The global Calcitonin Gene Related Peptide Type 1 Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Calcitonin Gene Related Peptide Type 1 Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Calcitonin Gene Related Peptide Type 1 Receptor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Calcitonin Gene Related Peptide Type 1 Receptor in...
  • 世界の抗生物質＆抗真菌薬市場 2019年
    DATA909X03624 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗生物質＆抗真菌薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ペニシリン、セファロスポリン、カルバペネム、マクロライド、アミノグリコシド、キノロン(フルオロキノロン)、スルホンアミド、テトラサイクリン、その他に、用途別には、病院薬局、小売薬局、オンライン薬局にセグメント区分し、抗生物質＆抗真菌薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗生物質＆抗真菌薬の世界市場概要 ・抗生物質＆抗真菌薬の製造コスト構成分析 ・抗生物質＆抗真菌薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗生物質＆抗真菌薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗生物質＆抗真菌薬のセグメント分析（種類別） （ペニシリン、セファロスポリン、カルバペネム、マクロライド、アミノグリコシド、キノロン(フルオロキノロン)、スルホンアミド、テトラサイクリン、その他）...The global Antibiotics and Antimycotics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Antibiotics and Antimycotics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antibiotics and Antimycotics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Antibiotics and Antimycotics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界の獣医用抗生物質市場 2019年
    DATA909X17395 / QYResearch / 2019年11月22日 / ※本調査レポートは、獣医用抗生物質の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、テトラサイクリン、ペニシリン、マクロライド、スルホンアミド、アミノグリコシド、その他に、用途別には、家畜、伴侶動物にセグメント区分し、獣医用抗生物質の世界市場を分析しました。 ・エグゼクティブ・サマリー ・獣医用抗生物質の世界市場概要 ・獣医用抗生物質の製造コスト構成分析 ・獣医用抗生物質の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・獣医用抗生物質の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・獣医用抗生物質のセグメント分析（種類別） （テトラサイクリン、ペニシリン、マクロライド、スルホンアミド、アミノグリコシド、その他）...The global Veterinary Antibiotics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Veterinary Antibiotics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Veterinary Antibiotics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Veterinary Antibiotics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Veterinary Antibiotics manufacturing...
  • 世界の動物用抗生物質＆抗菌薬市場 2019年
    DATA909X03572 / QYResearch / 2019年11月15日 / ※本調査レポートは、動物用抗生物質＆抗菌薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、テトラサイクリン、ペニシリン、マクロライド、アミノグリコシド、スルホンアミド、フルオロキノロン、リンコサミド、セファロスポリン、その他に、用途別には、食用動物、愛玩動物にセグメント区分し、動物用抗生物質＆抗菌薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・動物用抗生物質＆抗菌薬の世界市場概要 ・動物用抗生物質＆抗菌薬の製造コスト構成分析 ・動物用抗生物質＆抗菌薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・動物用抗生物質＆抗菌薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・動物用抗生物質＆抗菌薬のセグメント分析（種類別） （テトラサイクリン、ペニシリン、マクロライド、アミノグリコシド、スルホンアミド、フルオロキノロン、リンコサミド、セファロスポリン、その他）...The global Animal Antibiotics and Antimicrobials market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Animal Antibiotics and Antimicrobials volume and value at global level, regional level and company level. From a global perspective, this report represents overall Animal Antibiotics and Antimicrobials market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Animal Antibiotics and Antimicrobials in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の抗炎症性抗生物質点眼剤市場 2019年
    DATA909X03655 / QYResearch / 2019年11月15日 / ※本調査レポートは、抗炎症性抗生物質点眼剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、クロラムフェニコール、リファンピシン、ノルフロキサシン、モイスン、エリスロマイシンに、用途別には、大人、子供にセグメント区分し、抗炎症性抗生物質点眼剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・抗炎症性抗生物質点眼剤の世界市場概要 ・抗炎症性抗生物質点眼剤の製造コスト構成分析 ・抗炎症性抗生物質点眼剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・抗炎症性抗生物質点眼剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・抗炎症性抗生物質点眼剤のセグメント分析（種類別） （クロラムフェニコール、リファンピシン、ノルフロキサシン、モイスン、エリスロマイシン）...The global Anti-inflammatory antibiotics EyeDrops market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Anti-inflammatory antibiotics EyeDrops volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-inflammatory antibiotics EyeDrops market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Anti-inflammatory antibiotics EyeDrops in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆